Goldman Sachs Recommends Biogen Idec (BIIB) Calls, Says Co A Takeover Target - Bloomberg
Tweet Send to a Friend
Goldman Sachs is out recommending 6-month ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
